September 15, 2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Neoadjuvant chemotherapy followed by radical cystectomy is the standard treatment for cisplatin-eligible patients with muscle-invasive bladder cancer. Adding perioperative immunotherapy may improve outcomes.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Thomas Powles

James W.F. Catto

Matthew D. Galsky

Journals

New England Journal of Medicine

Actions

Institutions

University of Sheffield

Queen Mary University of London

Barts Health NHS Trust

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study